Oestrogens and endometrial hyperplasia.
D000230:Adenocarcinoma / Q000139:chemically induced; D000293:Adolescent; D000328:Adult; D000858:Anovulation / Q000150:complications; D002979:Climacteric / Q000187:drug effects; D004714:Endometrial Hyperplasia / Q000139:chemically induced* / Q000145:classification / Q000150:complications / Q000473:pathology; D004717:Endometrium / Q000648:ultrastructure; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause; D008855:Microscopy, Electron, Scanning; D009765:Obesity / Q000150:complications; D010051:Ovarian Neoplasms / Q000150:complications; D010298:Parity; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011374:Progesterone / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000139:chemically induced
D004967:Estrogens; D011374:Progesterone